Intracellular Signaling in Cancer

作者: Chittam U. Thakore , Brian D. Lehmann , James A. McCubrey , David M. Terrian

DOI: 10.1002/3527600906.MCB.200400106

关键词:

摘要: Cancer genes that encode protein kinases are the most commonly mutated class of to be causally linked progressive outgrowth malignant neoplasms. Protein operate as important molecular switches impinge, directly or indirectly, upon an integrated signaling circuitry often becomes genetically reprogrammed, through successive mutations, transmit many growth-stimulating and survival signals govern transformation normal human cells into a cancerous cell mass. Of 291 recently included in comprehensive catalog known cancer genes, 9.3% (27 distinct genes) kinase domain sequences. This number far exceeds random prediction 6.3 (2%) reinforces hypothesis vast majority carry genetic defects growth-signaling enable these grow autonomously evade cellular senescence death. First, we provide general overview prototypical circuit detailed analysis canonical Ras/Raf/MEK/ERK pathway, because it has central role signaling. is followed by discussion each cancer; will describe organization function(s) protein, its oncogenic alterations how this alters activity, identify tumor/cancer types which changes common. Keywords: Cancer Gene; Chromosomal Translocation; Human Kinome; Kinase Domain; Neoplasm

参考文章(72)
M Liyanage, D Frith, S Stabel, K Vollmer, G Kour, O Sözeri, G E Mark rd, Activation of the c-Raf protein kinase by protein kinase C phosphorylation. Oncogene. ,vol. 7, pp. 2259- 2262 ,(1992)
Floyd H. Thompson, Mark A. Nelson, Jeffrey M. Trent, Xin-Yuan Guan, Yun Liu, Jin-Ming Yang, Julia Emerson, Laurence Adair, Julie Wymer, Celia Balfour, Kathy Massey, Ronald Weinstein, David S. Alberts, Raymond Taetle, Amplification of 19q13.1–q13.2 sequences in ovarian cancer: G-band, FISH, and molecular studies Cancer Genetics and Cytogenetics. ,vol. 87, pp. 55- 62 ,(1996) , 10.1016/0165-4608(95)00248-0
Patrick C Ma, Gautam Maulik, James Christensen, Ravi Salgia, c-Met: Structure, functions and potential for therapeutic inhibition Cancer and Metastasis Reviews. ,vol. 22, pp. 309- 325 ,(2003) , 10.1023/A:1023768811842
Jacob Falck, Niels Mailand, Randi G. Syljuåsen, Jiri Bartek, Jiri Lukas, The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature. ,vol. 410, pp. 842- 847 ,(2001) , 10.1038/35071124
CE Carow, M Levenstein, SH Kaufmann, J Chen, S Amin, P Rockwell, L Witte, MJ Borowitz, CI Civin, D Small, Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias. Blood. ,vol. 87, pp. 1089- 1096 ,(1996) , 10.1182/BLOOD.V87.3.1089.BLOODJOURNAL8731089
L S Steelman, S C Pohnert, J G Shelton, R A Franklin, F E Bertrand, J A McCubrey, JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia. ,vol. 18, pp. 189- 218 ,(2004) , 10.1038/SJ.LEU.2403241
Ren-Yuan Bai, Tao Ouyang, Cornelius Miething, Stephan W. Morris, Christian Peschel, Justus Duyster, Nucleophosmin–anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway Blood. ,vol. 96, pp. 4319- 4327 ,(2000) , 10.1182/BLOOD.V96.13.4319
Giovanni Cazzaniga, Sabrina Tosi, Alessandra Aloisi, Giovanni Giudici, Maria Daniotti, Pietro Pioltelli, Lyndal Kearney, Andrea Biondi, The Tyrosine Kinase Abl-Related Gene ARG Is Fused toETV6 in an AML-M4Eo Patient With a t(1;12)(q25;p13): Molecular Cloning of Both Reciprocal Transcripts Blood. ,vol. 94, pp. 4370- 4373 ,(1999) , 10.1182/BLOOD.V94.12.4370
Xin Yuan Guan, Dan Xie, Jonathan S.T. Sham, Terence C.M. Tang, Qiu Liang Wu, Ke Ke Huo, Yan Fang, Identification of a candidate oncogene SEI-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines Cancer Research. ,vol. 62, pp. 7157- 7161 ,(2002)
Virginie Lacronique, Anthony Boureux, Richard Monni, Stephanie Dumon, Martine Mauchauffé, Patrick Mayeux, Fabrice Gouilleux, Roland Berger, Sylvie Gisselbrecht, Jacques Ghysdael, Olivier A. Bernard, Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. Blood. ,vol. 95, pp. 2076- 2083 ,(2000) , 10.1182/BLOOD.V95.6.2076